key: cord-0945762-xafi1ujk
authors: Anusim, Nwabundo; Gupta, Ruby; Ahaneku, Hyceinth; Franklin, Candace; Balaraman, Savitha; Huben, Marianne; Jaiyesimi, Ishmael
title: Presentation, management, and outcomes of COVID‐19 in patients with sickle cell disease
date: 2021-01-12
journal: EJHaem
DOI: 10.1002/jha2.162
sha: 15bf1c1224bda810ad8963214dce087fdb86658e
doc_id: 945762
cord_uid: xafi1ujk

nan

During this study period, a total of 11 patients with sickle cell disease were identified as having a positive SARS-Cov19 polymerase chain reaction test (Table 1 ). All were Black race, predominantly female (7/11, 64%) with a mean (range) age of 44 (22-60) years and mean BMI of 30.2 kg/m 2 . Genotypes identified were HbSS in five (45%) patients, HbSC in four (36%), HbS/β-thalassemia (+) in one (9%), and HbS/αthalassemia in one (9%). Seventy-two percent of patients reported at least one complication of sickle cell disease and all patients had been evaluated at least once by a hematologist since the diagnosis of SCD; none of the patients were receiving chronic transfusions, hydroxyurea, voxeloter, L-glutamine oral powder, or crizanlizumab at admission.

The most common clinical presentations were fever, chest pain, chills, exertional shortness of breath, and cough but this was not consistent across all patients. Two patients presented with bone pain and were incidentally found to have imaging features of COVID-19. All patients were managed with intravenous hydration and pain manage- [5] . In a comprehensive multicentre review of 19 sickle cell patients with COVID-19, each center treated patients rather differently without a guiding protocol [4] . The American Society of Hematology provides resources for the management of SCD patients with COVID-19 [6] . We continue to seek to improve management of sickle cell patients and we encourage patients to participate in clinical trials.

Nwabundo Anusim https://orcid.org/0000-0002-9984-5390

Sickle cell disease; An overview of the disease and its systemic effects

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

demographic characteristics, and geographic distribution of sickle cell trait and sickle cell anemia births in Michigan

Managing sickle cell patients with COVID-19 infection: The need to pool our collective experience

Cappellini MD Care of patients with hemoglobin disorders during the COVID-19 pandemic: An overview of recommendations

Sickle cell disease patients presesnting to the emergency department during the COVID-19 pandemic: Considerations and a checklist